Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 06, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Announces Issuance by USPTO of Additional Patent Directed to LIPO-202 Lead Clinical Asset

SAN DIEGO, Oct. 6, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
September 30, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Initiates Study to Evaluate the Safety of LIPO-202 for Body Contouring in Obese Subjects

SAN DIEGO, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
September 28, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Expands Its Board of Directors With Appointments of Jeffrey Nugent and Hani Zeini

SAN DIEGO, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it has named Jeffrey Nugent and Hani Zeini to its Board of Directors. Mr. Nugent is a respected...
September 21, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics to Present at the OC Summit on Aesthetics and Dermatology

SAN DIEGO, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
September 08, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Announces Last Patient Enrolled in LIPO-202 Pivotal Phase 3 Clinical Trials for Reduction of Subcutaneous Abdominal Fat

SAN DIEGO, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...
August 13, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Reports Second Quarter 2015 Financial Results

SAN DIEGO, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
August 06, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics to Release Second Quarter 2015 Financial Results

SAN DIEGO, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it...
August 06, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Announces Reaffirmation of Patents and Termination of Reexamination Challenge by United States Patent and Trademark Office

SAN DIEGO, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
June 30, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Initiates Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 for Body Contouring

SAN DIEGO, June 30, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
May 14, 2015 08:00 ET | Source: Neothetics, Inc.

Neothetics Reports First Quarter 2015 Financial Results

SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported financial...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right